Search | Page 14 | Aplastic Anemia and MDS International Foundation

Search

Search results

  1. What are the treatments for MDS?

    ... of healthy bone marrow cells. These therapies include lenalidomide (Revlimid), decitaibine (Dacogen) and azacitidine ...

    FAQ last updated 03/15/2016 - 11:31pm.

  2. Prognostic Relevance of the Kinetics of Worsening of Cytopenias in Lower-Risk MDS: A Substudy from the European Leukemianet Low Risk MDS (EUMDS) Registry

    ... colony-stimulating factor, hydroxyurea, or Revlimid® ( lenalidomide ). Patients’ median age was 73 years, and 59% were male. ...

    Research Review last updated 05/02/2016 - 9:27am.

  3. PRO#1278: Fludarabine and Busulfan vs. Fludarabine, Busulfan and Total Body Irradiation (FLUBUTBI)

    ... initiating treatment in this study with the exception of lenalidomide , decitabine , azacitidine , imatinib mesylate, ...

    Clinical Trial last updated 04/29/2016 - 3:09pm.

  4. Incidence and Burden of the Myelodysplastic Syndromes

    ... even though treatments such as azacitidine and lenalidomide have been shown to decrease red blood cell transfusion ...

    Research Review last updated 05/02/2016 - 9:11am.

  5. Therapies

    ... low- and high-risk patients with all sub-types of MDS. Lenalidomide (Revlimid®) is approved for transfusion-dependent MDS ...

    Page last updated 03/18/2016 - 11:26am.

  6. Myelodysplastic syndromes: What do hospitalists need to know?

    ... are offered erythropoiesis-stimulating agents (ESAs), lenalidomide , and immununosuppressive therapy.  ESAs are injections ... risk of blood clots in MDS unlike in other malignancies.  Lenalidomide (Revlimid®) has been used primarily in patients with a ...

    Research Review last updated 05/02/2016 - 9:21am.

  7. Treatments

    ... low- and high-risk patients with all sub-types of MDS. Lenalidomide (Revlimid®) is approved for transfusion-dependent MDS ...

    Topic section last updated 03/30/2016 - 3:13pm.

  8. Donor Stem Cell Transplant in Treating Patients With High Risk Acute Myeloid Leukemia

    ... demethylating agents (azacytidine or decitabine , lenalidomide , etc) ALLOWED. Cohort B: Patients who have received prior ...

    Clinical Trial last updated 06/13/2016 - 3:31pm.

  9. Clinical Trial Basics

    ... (Dacogen) deferasirox (Exjade) lenalidomide (Revlimid) eculizumab (Soliris) ...

    Page last updated 03/29/2016 - 7:29pm.

  10. Amer Zeidan, M.D.

    ... and his colleagues confirmed the clinical benefits of lenalidomide and iron chelation therapy in patients with MDS at the ...

    Bio last updated 03/11/2016 - 1:41pm.